Scientists at the University of Oxford, led by Professor Ahmed Ahmed, are designing OvarianVax, a vaccine which teaches the immune system to recognise and attack the earliest stages of ovarian cancer. The team will receive up to £600,000 for the study over the next three years to support lab research into the vaccine.
In this study, the CRUK-funded researchers will establish the targets for the vaccine. They will find out which proteins on the surface of early-stage ovarian cancer cells are most strongly recognised by the immune system and how effectively the vaccine kills mini-models of ovarian cancer called organoids.
If this research is successful, work will then begin on clinical trials of the vaccine. The hope is that in the future, women could be offered this vaccine to prevent ovarian cancer in the first place.
Read the full story on the MRC Weatherall Institute of Molecular Medicine (MRC WIMM) website.
more recommended stories
HPV-Negative Head & Neck Cancer: Hope in ImmunotherapyA groundbreaking Phase 2 clinical trial.
Neuroscientists Map the Brain’s Speech & Language PathwaysA groundbreaking study has revealed how.
Can Social Media Abstinence Improve Well-Being? Not ReallyA new systematic review and meta-analysis.
Weekend Effect: Higher Mortality for Friday SurgeriesA recent study published in JAMA.
Chronic Cocaine Use Increases Impulsivity, Study FindsA recent study published in eNeuro.
Father’s Diet & BMI Don’t Affect Newborn’s Birth WeightA recent study published in Nutrients.
Stem Cell Therapy Shows 92% Success in Corneal RepairA groundbreaking stem cell therapy known.
How Subtle Pitch Changes Affect Speech UnderstandingA groundbreaking study by Northwestern University,.
How Gut Bacteria Convert Sugar into Essential Fatty AcidsA recent study by Kobe University.
Gene Therapy for Maple Syrup Urine DiseaseResearchers at UMass Chan Medical School.
Leave a Comment